Extremely high titer of anti-human chimeric antibody following re-treatment with rituximab in a patient with active systemic lupus erythematosus

被引：17

作者：

Saito, K ^{[1
]}

Nawata, M ^{[1
]}

Iwata, S ^{[1
]}

Tokunaga, M ^{[1
]}

Tanaka, Y ^{[1
]}

机构：

[1] Univ Occupat & Environm Hlth, Sch Med, Dept Internal Med 1, Yahatanishi Ku, Kitakyushu, Fukuoka 8078555, Japan

来源：

RHEUMATOLOGY | 2005年 / 44卷 / 11期

关键词：

D O I：

10.1093/rheumatology/kei075

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1462 / 1464

页数：5

共 11 条

[1] Intravenous hydrocortisone premedication reduces antibodies to infliximab in Crohn's disease: A randomized controlled trial [J].

Farrell, RJ ;

Alsahli, M ;

Jeen, YT ;

Falchuk, KR ;

Peppercorn, MA ;

Michetti, P .

GASTROENTEROLOGY, 2003, 124 (04) :917-924

[2] An open study of B lymphocyte depletion in systemic lupus erythematosus [J].

Leandro, MJ ;

Edwards, JC ;

Cambridge, G ;

Ehrenstein, MR ;

Isenberg, DA .

ARTHRITIS AND RHEUMATISM, 2002, 46 (10) :2673-2677

[3] B cell depletion as a novel treatment for systemic lupus erythematosus - A phase I/II dose-escalation trial of rituximab [J].

Looney, RJ ;

Anolik, JH ;

Campbell, D ;

Felgar, RE ;

Young, F ;

Arend, LJ ;

Sloand, JA ;

Rosenblatt, J ;

Sanz, I .

ARTHRITIS AND RHEUMATISM, 2004, 50 (08) :2580-2589

[4]

Maini RN, 1998, ARTHRITIS RHEUM, V41, P1552, DOI 10.1002/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO

[5]

2-W

[6] Rituximab chimeric Anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma:: Half of patients respond to a four-dose treatment program [J].

McLaughlin, P ;

Grillo-López, AJ ;

Link, BK ;

Levy, R ;

Czuczman, MS ;

Williams, ME ;

Heyman, MR ;

Bence-Bruckler, I ;

White, CA ;

Cabanillas, F ;

Jain, V ;

Ho, AD ;

Lister, J ;

Wey, K ;

Shen, D ;

Dallaire, BK .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) :2825-2833

[7]

REFF ME, 1994, BLOOD, V83, P435

[8] Successful treatment with anti-CD20 monoclonal antibody (rituximab) of life-threatening refractory systemic lupus erythematosus with renal and central nervous system involvement [J].

Saito, K ;

Nawata, M ;

Nakayamada, S ;

Tokunaga, M ;

Tsukada, J ;

Tanaka, Y .

LUPUS, 2003, 12 (10) :798-800

[9] Preventing antibodies to infliximab in patients with Crohn's disease: Optimize not immunize [J].

Sandborn, WJ .

GASTROENTEROLOGY, 2003, 124 (04) :1140-1145

[10] Down-regulation of CD40 and CD80 on B cells in patients with life-threatening systemic lupus erythematosus after successful treatment with rituximab [J].

Tokunaga, M ;

Fujii, K ;

Saito, K ;

Nakayamada, S ;

Tsujimura, S ;

Nawata, M ;

Tanaka, Y .

RHEUMATOLOGY, 2005, 44 (02) :176-182

← 1 2 →